Embecta Corp. (EMBC)
6.21
-0.06
(-0.96%)
USD |
NASDAQ |
Oct 19, 16:00
6.22
+0.01
(+0.16%)
After-Hours: 20:00
Embecta Debt to Equity Ratio : -2.451 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.451 |
| March 31, 2026 | -2.192 |
| December 31, 2025 | -2.300 |
| September 30, 2025 | -2.225 |
| June 30, 2025 | -2.266 |
| March 31, 2025 | -2.131 |
| December 31, 2024 | -2.072 |
| September 30, 2024 | -2.203 |
| June 30, 2024 | -2.164 |
| March 31, 2024 | -2.151 |
| Date | Value |
|---|---|
| December 31, 2023 | -2.089 |
| September 30, 2023 | -2.02 |
| June 30, 2023 | -2.049 |
| March 31, 2023 | -2.018 |
| December 31, 2022 | -1.973 |
| September 30, 2022 | -1.851 |
| June 30, 2022 | -1.947 |
| March 31, 2022 | -1.461 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.0067 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Artivion, Inc. | 0.9156 |
| Abbott Laboratories | 0.638 |
| AngioDynamics, Inc. | 0.0655 |
| Alphatec Holdings, Inc. | 52.37 |
| AtriCure, Inc. | 0.1437 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.265B |
| Total Liabilities (Quarterly) | 1.878B |
| Shareholders Equity (Quarterly) | -612.70M |
| Current Ratio | 1.680 |
| Net Debt Paydown Yield | 7.24% |